CN103278622A - Preparation method of 96-well enzyme label plate chloramphenicol molecularly imprinted polymer film - Google Patents
Preparation method of 96-well enzyme label plate chloramphenicol molecularly imprinted polymer film Download PDFInfo
- Publication number
- CN103278622A CN103278622A CN2013101522466A CN201310152246A CN103278622A CN 103278622 A CN103278622 A CN 103278622A CN 2013101522466 A CN2013101522466 A CN 2013101522466A CN 201310152246 A CN201310152246 A CN 201310152246A CN 103278622 A CN103278622 A CN 103278622A
- Authority
- CN
- China
- Prior art keywords
- chloramphenicol
- hours
- elisa plate
- chloromycetin
- ultrasonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 title claims abstract description 53
- 229960005091 chloramphenicol Drugs 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims description 8
- 229920000344 molecularly imprinted polymer Polymers 0.000 title abstract description 10
- 102000004190 Enzymes Human genes 0.000 title description 11
- 108090000790 Enzymes Proteins 0.000 title description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000012528 membrane Substances 0.000 claims abstract description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract 2
- 238000002965 ELISA Methods 0.000 claims description 20
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 5
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- 229940097572 chloromycetin Drugs 0.000 claims 5
- 238000007789 sealing Methods 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000004132 cross linking Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000004088 foaming agent Substances 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 9
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 abstract description 8
- 239000003999 initiator Substances 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- ZCHPKWUIAASXPV-UHFFFAOYSA-N acetic acid;methanol Chemical compound OC.CC(O)=O ZCHPKWUIAASXPV-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003361 porogen Substances 0.000 abstract description 3
- 150000002009 diols Chemical class 0.000 abstract description 2
- 238000001514 detection method Methods 0.000 description 15
- 238000003018 immunoassay Methods 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000005281 excited state Effects 0.000 description 3
- 230000008105 immune reaction Effects 0.000 description 3
- 241000251511 Holothuroidea Species 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 239000003640 drug residue Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- WIIZWVCIJKGZOK-IUCAKERBSA-N 2,2-dichloro-n-[(1s,2s)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide Chemical compound ClC(Cl)C(=O)N[C@@H](CO)[C@@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-IUCAKERBSA-N 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000005081 chemiluminescent agent Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004808 supercritical fluid chromatography Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开一种96孔酶标板氯霉素分子印迹聚合膜的制备方法,按如下步骤进行:将模板分子氯霉素、功能单体甲基丙烯酸二乙基氨基乙酯和交联剂乙二醇二甲基丙烯酸酯按照摩尔比1:4:0.2溶解于致孔剂四氢呋喃中,超声30min;所述四氢呋喃的用量为5ml/0.25mmol氯霉素;加入引发剂偶氮二异丁腈,超声15min,加入量为5mg/0.25mmol氯霉素;将b步骤所得溶液滴加到96孔酶标板上,之后将96孔酶标板放入密封袋中,充入氮气,密封且紫外灯照射条件下,引发聚合6小时;再将96孔酶标板置于体积比为3:1的甲醇—乙酸混合液中,超声洗脱48小时;50℃干燥96孔酶标板2小时,得到氯霉素分子印迹聚合膜。
The invention discloses a method for preparing a chloramphenicol molecularly imprinted polymer film on a 96-well microplate plate. Diol dimethacrylate was dissolved in porogen tetrahydrofuran at a molar ratio of 1:4:0.2, and ultrasonicated for 30 minutes; the amount of tetrahydrofuran was 5ml/0.25mmol chloramphenicol; the initiator azobisisobutyronitrile was added, Sonicate for 15 minutes, add 5mg/0.25mmol chloramphenicol; drop the solution obtained in step b onto a 96-well microplate, then put the 96-well microplate into a sealed bag, fill it with nitrogen, seal it and put it under the ultraviolet light Under the condition of irradiation, polymerization was initiated for 6 hours; then the 96-well microplate was placed in a methanol-acetic acid mixture with a volume ratio of 3:1, and ultrasonically eluted for 48 hours; the 96-well microplate was dried at 50°C for 2 hours to obtain Chloramphenicol Molecularly Imprinted Polymeric Membrane.
Description
技术领域 technical field
本发明涉及一种分子印迹聚合物膜的制备方法,尤其是一种对氯霉素高选择性吸附的96孔酶标板氯霉素分子印迹聚合膜的制备方法。 The invention relates to a method for preparing a molecularly imprinted polymer film, in particular to a method for preparing a chloramphenicol molecularly imprinted polymer film on a 96-hole microplate plate with high selective adsorption of chloramphenicol.
背景技术 Background technique
氯霉素(Chloramphenicol,CAP) 是1947年首次从微生物代谢物中分离得到的抗生素,由于其优良的抗菌性、稳定的药性、低廉的价格,已广泛作为饲料添加剂,用于治疗细菌性疾病。然而,由于其苯环上带硝基,其分解半衰期较长而且具有严重的毒副作用,易引起人体血中毒,导致不可逆的再生障碍性贫血等严重的毒副作用,对人类的健康构成巨大的潜在威胁。因此,欧盟、美国均在法规中规定CAP的残留限量标准为“零容许量”,我国农业部也规定CAP及其盐、脂等在食品动物的所有可食组织中不得检出。目前,对于样品中残留的CAP检测方法主要有微生物法、免疫分析法、气相色谱法、色谱质谱联用法、超临界流体色谱法以及免疫荧光毛细管电泳技术等。现有检测方法对于样品前处理步骤繁琐,加之样基体成分复杂、CAP残留浓度低,难以实现快速有效检测。 Chloramphenicol (Chloramphenicol, CAP) is an antibiotic isolated from microbial metabolites for the first time in 1947. Due to its excellent antibacterial properties, stable drug properties, and low price, it has been widely used as a feed additive to treat bacterial diseases. However, due to the nitro group on its benzene ring, its decomposition half-life is long and has serious toxic side effects, which can easily cause human blood poisoning, lead to serious toxic side effects such as irreversible aplastic anemia, and constitute a huge potential for human health. threaten. Therefore, the European Union and the United States have stipulated in the regulations that the CAP residue limit standard is "zero tolerance". The Ministry of Agriculture of my country also stipulates that CAP and its salt, fat, etc. should not be detected in all edible tissues of food animals. At present, the detection methods for CAP residues in samples mainly include microbiological methods, immunoassay methods, gas chromatography, chromatography-mass spectrometry, supercritical fluid chromatography, and immunofluorescence capillary electrophoresis techniques. Existing detection methods are cumbersome for sample pretreatment steps, coupled with complex sample matrix components and low CAP residual concentration, it is difficult to achieve rapid and effective detection.
免疫分析法具有操作简单、快速、灵敏度高、特异性强及检测费用低等优点,被国外许多国家列为优先研究、开发和利用的农药残留分析技术。目前使用的免疫分析技术主要是酶联免疫(ELISA)分析方法,但检出限在0.1μg/L,有时候难以达到药残检测标准要求。化学发光免疫测定是继酶免技术后发展的一种新兴免疫测定技术,是用化学发光剂直接标记抗原或抗体的免疫分析方法。化学发光免疫分析仪包含两个部分,即免疫反应系统和化学发光分析系统。免疫反应系统是将发光物质(在反应剂激发下生成激发态中间体)直接标记在抗原(化学发光免疫分析) 或抗体(免疫化学发光分析)上,或酶作用于发光底物。化学发光分析系统是利用化学发光物质经催化剂的催化和氧化剂的氧化,形成一个激发态的中间体,当这种激发态中间体回到稳定的基态时,同时发射出光子(hM),利用发光信号测量仪器测量光量子产额。虽然化学发光免疫检测技术的灵敏度很容易达到0.01μg/L水平,但是免疫反应系统所用的试剂盒中抗体的制备过程繁琐复杂、费用高、所用仪器昂贵,不适用于大批量样品药物残留的检测。 Immunoassay has the advantages of simple operation, rapidity, high sensitivity, strong specificity and low detection cost, and has been listed as a priority research, development and utilization of pesticide residue analysis technology by many foreign countries. The currently used immunoassay technique is mainly enzyme-linked immunosorbent assay (ELISA) analysis method, but the detection limit is 0.1 μg/L, and sometimes it is difficult to meet the requirements of the drug residue detection standard. Chemiluminescent immunoassay is a new immunoassay technology developed after enzyme immunoassay technology. It is an immunoassay method that uses chemiluminescent agents to directly label antigens or antibodies. The chemiluminescence immunoassay analyzer consists of two parts, the immune reaction system and the chemiluminescence analysis system. The immune reaction system is to directly label the luminescent substance (excited state intermediate generated under the excitation of the reactant) on the antigen (chemiluminescence immunoassay) or antibody (immunochemiluminescence assay), or the enzyme acts on the luminescent substrate. The chemiluminescent analysis system uses chemiluminescent substances to form an excited state intermediate through the catalysis of the catalyst and the oxidation of the oxidant. When the excited state intermediate returns to the stable ground state, it emits photons (hM) at the same time. The signal measurement instrument measures the photon quantum yield. Although the sensitivity of chemiluminescence immunoassay technology can easily reach the level of 0.01 μg/L, the preparation process of the antibody in the kit used in the immune reaction system is cumbersome and complicated, the cost is high, and the equipment used is expensive, which is not suitable for the detection of drug residues in large batches of samples .
分子印迹技术(molecular imprinting technology MIT)其基本原理是将模板分子(待分离、识别的分子)同具有适合官能团的功能单体相互作用,在交联剂和引发剂的作用下形成具有大孔、网状的聚合物,通过溶剂洗脱或在一定条件下水解除去模板分子,聚合物中就留下了大小、形状及功能基团与模板分子匹配的“记忆”空穴,这样的空穴便可以与混合物中待分离的模板分子进行特异性的亲和作用,从而达到分离、纯化、预富集模板分子等,继而用酶联免疫等化学发光方法,可实现对样品中模板分子的快速、有效检测。但是,迄今为止还没有关于制备氯霉素分子印迹聚合物膜的相关报道。 The basic principle of molecular imprinting technology (MIT) is to interact template molecules (molecules to be separated and identified) with functional monomers with suitable functional groups, and form macropores, For network polymers, template molecules are removed by solvent elution or hydrolysis under certain conditions, leaving a "memory" hole in the polymer that matches the template molecule in size, shape, and functional groups. It can carry out specific affinity with the template molecules to be separated in the mixture, so as to achieve separation, purification, pre-enrichment of template molecules, etc., and then use chemiluminescence methods such as enzyme-linked immunosorbent immunoassays to realize rapid and accurate detection of template molecules in samples. effective detection. However, so far there is no relevant report on the preparation of molecularly imprinted polymer membranes of chloramphenicol.
发明内容 Contents of the invention
本发明是为了解决现有技术所存在的上述技术问题,提供一种对氯霉素高选择性吸附的96孔酶标板氯霉素分子印迹聚合膜的制备方法。 The present invention aims to solve the above-mentioned technical problems existing in the prior art, and provides a method for preparing a chloramphenicol molecularly imprinted polymer membrane on a 96-well enzyme plate with high selective adsorption of chloramphenicol.
本发明的技术解决方案是:一种96孔酶标板氯霉素分子印迹聚合膜的制备方法,其特征在于按如下步骤进行: The technical solution of the present invention is: a kind of preparation method of chloramphenicol molecularly imprinted polymembrane of 96 well microplate plate, it is characterized in that carry out according to following steps:
a. 将模板分子氯霉素、功能单体甲基丙烯酸二乙基氨基乙酯和交联剂乙二醇二甲基丙烯酸酯按照摩尔比1:4:0.2溶解于致孔剂四氢呋喃中,超声30min;所述四氢呋喃的用量为5ml/0.25mmol氯霉素; a. Dissolve the template molecule chloramphenicol, the functional monomer diethylaminoethyl methacrylate and the cross-linking agent ethylene glycol dimethacrylate in the porogen tetrahydrofuran at a molar ratio of 1:4:0.2, and ultrasonically 30min; the consumption of described tetrahydrofuran is 5ml/0.25mmol chloramphenicol;
b. 加入引发剂偶氮二异丁腈,超声15min,加入量为5mg/0.25mmol氯霉素; b. Add the initiator azobisisobutyronitrile, ultrasonic for 15min, and the addition amount is 5mg/0.25mmol chloramphenicol;
c. 将b步骤所得溶液滴加到96孔酶标板上,之后将96孔酶标板放入密封袋中,充入氮气,密封且紫外灯照射条件下,引发聚合6小时; c. Add the solution obtained in step b to a 96-well microtiter plate dropwise, then put the 96-well microtiter plate into a sealed bag, fill it with nitrogen gas, seal it and irradiate it with a UV lamp, and initiate polymerization for 6 hours;
d. 再将96孔酶标板置于体积比为3:1的甲醇—乙酸混合液中,超声洗脱48小时; d. Then place the 96-well ELISA plate in a methanol-acetic acid mixture with a volume ratio of 3:1, and ultrasonically elute for 48 hours;
e. 50℃干燥96孔酶标板2小时,得到氯霉素分子印迹聚合膜。 e. Dry the 96-well ELISA plate at 50°C for 2 hours to obtain a chloramphenicol molecularly imprinted polymer membrane.
所述a步骤是称取0.25mmol氯霉素于烧瓶中,向其中加入5ml四氢呋喃,超声5min;待氯霉素溶解后,加人1mmol甲基丙烯酸二乙基氨基乙酯,超声20min;再将0.05mmol乙二醇二甲基丙烯酸酯加入到烧瓶中,超声5min。 The a step is to weigh 0.25mmol chloramphenicol in a flask, add 5ml tetrahydrofuran to it, and ultrasonicate for 5min; Add 0.05mmol ethylene glycol dimethacrylate into the flask, and ultrasonicate for 5min.
本发明是以甲基丙烯酸二乙基氨基乙酯为功能单体,以乙二醇二甲基丙烯酸酯为交联剂、四氢呋喃为致孔剂、偶氮二异丁腈为引发剂,并按照特定比例及生产条件等,生产出具有非常高的选择性和特异性的氯霉素分子印迹聚合物膜,有较高的稳定性、较长的使用寿命和较强的抗恶劣环境能力。本发明成本低廉、操作简单、反应条件容易控制。 The present invention uses diethylaminoethyl methacrylate as a functional monomer, ethylene glycol dimethacrylate as a crosslinking agent, tetrahydrofuran as a porogen, and azobisisobutyronitrile as an initiator, and according to Specific ratios and production conditions, etc., produce chloramphenicol molecularly imprinted polymer membranes with very high selectivity and specificity, which have high stability, long service life and strong resistance to harsh environments. The invention has the advantages of low cost, simple operation and easy control of reaction conditions.
附图说明 Description of drawings
图1是本发明实施例直接竞争ELISA检测氯霉素的标准曲线图。 Fig. 1 is a standard curve diagram for the detection of chloramphenicol by direct competition ELISA according to the embodiment of the present invention.
具体实施方式 Detailed ways
a. 称取0.25mmol氯霉素于烧瓶中,向其中加入5ml四氢呋喃,超声5min;待氯霉素溶解后,加人1mmol甲基丙烯酸二乙基氨基乙酯,超声20min;再将0.05mmol乙二醇二甲基丙烯酸酯加入到烧瓶中,超声5min; a. Weigh 0.25mmol of chloramphenicol into a flask, add 5ml of tetrahydrofuran to it, and sonicate for 5 minutes; Diol dimethacrylate was added into the flask, ultrasonicated for 5min;
b. 加入5mg引发剂偶氮二异丁腈,超声15min; b. Add 5mg of initiator azobisisobutyronitrile, ultrasonic for 15min;
c. 将b步骤所得溶液滴加到96孔酶标板上,之后将96孔酶标板放入密封袋中,充入氮气,密封且100W紫外灯(λ=365nm)照射条件下,引发聚合6小时; c. Add the solution obtained in step b to the 96-well ELISA plate dropwise, then put the 96-well ELISA plate into a sealed bag, fill it with nitrogen gas, seal it and irradiate it with a 100W UV lamp (λ=365nm) to initiate polymerization 6 hours;
d. 再将96孔酶标板置于体积比为3:1的甲醇—乙酸混合液中,超声洗脱48小时,每四小时换一次洗脱液,去除模板分子; d. Then place the 96-well ELISA plate in a methanol-acetic acid mixture with a volume ratio of 3:1, ultrasonically elute for 48 hours, and change the eluent every four hours to remove template molecules;
e. 50℃干燥96孔酶标板2小时,得到氯霉素分子印迹聚合膜。 e. Dry the 96-well ELISA plate at 50°C for 2 hours to obtain a chloramphenicol molecularly imprinted polymer membrane.
试验: test:
1.合成酶标抗原(酶标氯霉素): 1. Synthetic enzyme-labeled antigen (enzyme-labeled chloramphenicol):
用戊二醛法将氯霉素偶联到辣根过氧化物酶上来合成酶标抗原,步骤如下: Use glutaraldehyde method to couple chloramphenicol to horseradish peroxidase to synthesize enzyme-labeled antigen. The steps are as follows:
(1)取100mg的氯霉素,加入到10ml 0.6mol/L的盐酸中; (1) Take 100mg of chloramphenicol and add it to 10ml of 0.6mol/L hydrochloric acid;
(2)待氯霉素溶解后,往其中加入60mg的锌粉,于80℃反应30min; (2) After the chloramphenicol is dissolved, add 60mg of zinc powder to it, and react at 80°C for 30min;
(3)取上清液冷却到室温,在搅拌下缓缓加入到含辣根过氧化物酶的缓冲溶液中,然后再滴加0.2ml 25%的戊二醛,磁力搅拌室温反应5h; (3) Take the supernatant and cool it to room temperature, slowly add it into the buffer solution containing horseradish peroxidase under stirring, then add 0.2ml of 25% glutaraldehyde dropwise, and react at room temperature for 5 hours with magnetic stirring;
(4)搅拌结束后,在4℃下将合成的产物对0.1mol/L、pH=7.2的PBS缓冲液(磷酸盐缓冲系统)透析3d,每天更换2次PBS缓冲液,以除去未反应的小分子物质戊二醛、氯霉素等; (4) After the stirring, the synthesized product was dialyzed against 0.1mol/L, pH=7.2 PBS buffer (phosphate buffer system) at 4°C for 3 days, and the PBS buffer was changed twice a day to remove untreated Reactive small molecule substances such as glutaraldehyde, chloramphenicol, etc.;
(5)量取透析袋中酶标抗原溶液的体积,再加入等体积的甘油,于-20℃冰箱避光保存备用。 (5) Measure the volume of the enzyme-labeled antigen solution in the dialysis bag, then add an equal volume of glycerol, and store it in a -20°C refrigerator in the dark for future use.
2.氯霉素标准品的准备 2. Preparation of Chloramphenicol Standards
配制100mg/L氯霉素甲醇溶液,然后将其用含有5%甲醇的PBS缓冲溶液稀释成30mg/L,再依次稀释至3mg/L、0.3mg/L、0.03mg/L、0.003mg/L、0.0003mg/L。测得各个浓度的发光值,来绘制氯霉素的标准曲线。 Prepare 100mg/L chloramphenicol methanol solution, then dilute it to 30mg/L with PBS buffer solution containing 5% methanol, and then dilute to 3mg/L, 0.3mg/L, 0.03mg/L, 0.003mg/L , 0.0003mg/L. The luminescence value of each concentration was measured to draw a standard curve of chloramphenicol.
3.直接竞争酶联免疫法检测: 3. Direct Competitive ELISA Assay:
(1)在氯霉素分子印迹聚合膜的96孔板上,每孔先加入100μl氯霉素样品标准溶液或氯霉素添加样品溶液; (1) Add 100 μl chloramphenicol sample standard solution or chloramphenicol-added sample solution to each well on a 96-well plate of chloramphenicol molecularly imprinted polymer membrane;
(2)然后往每孔加100μl酶标抗原溶液,以不加氯霉素标准溶液的孔为对照孔; (2) Then add 100 μl enzyme-labeled antigen solution to each well, and use the wells without chloramphenicol standard solution as control wells;
(3)室温孵育1h后,弃上清,用PBST洗板4-5次; (3) After incubating at room temperature for 1 hour, discard the supernatant and wash the plate 4-5 times with PBST;
(4)在洗板同时配制好发光液(鲁米诺和H2O21:1混合),将板放入化学免疫分析仪,加入发光液250μl/孔,在化学发光仪上读取发光强度发光值; (4) While washing the plate, prepare the luminescence solution (mixed with luminol and H 2 O 2 1:1), put the plate into the chemical immunoassay analyzer, add 250 μl/well of the luminescence solution, and read the luminescence on the chemiluminescence instrument intensity luminous value;
(5)重复测定6次,将样品发光值均值代入氯霉素标准曲线,得到氯霉素残留量。 (5) Repeat the measurement 6 times, and substitute the average luminescence value of the sample into the chloramphenicol standard curve to obtain the residual amount of chloramphenicol.
4.待测样品的准备和氯霉素试剂盒的验证 4. Preparation of samples to be tested and validation of the chloramphenicol kit
取一只健康海参,经液相检测,其体腔液中无氯霉素,用注射器从其中分别抽取体腔液于试管中,用0.45μm的滤膜过滤后,分别取1ml于3个试管中(给试管编号1,2,3),将0.02ml、0.1ml、0.2ml的浓度为0.05mg/L的氯霉素甲醇溶液分别填加到1、2、3号试管中,用体腔液配制成1μg/L、5μg/L、10μg/L的待测样品。应用氯霉素快速检测试剂盒和直接竞争ELISA(应用人工抗体)的检测结果如下:
Take a healthy sea cucumber, and it is detected by liquid phase that there is no chloramphenicol in its body cavity fluid. Use a syringe to extract the body cavity fluid from it into test tubes, filter it with a 0.45 μm filter membrane, and take 1ml into 3 test tubes ( Number the
直接竞争 ELISA(应用人工抗体)和氯霉素试剂盒对海参体腔液样品中添加氯霉素的检测结果 Detection results of direct competition ELISA (application of artificial antibody) and chloramphenicol kit for adding chloramphenicol in sea cucumber body cavity fluid samples
5.应用人工抗体的ELISA检测氯霉素的标准曲线 5. Standard Curve of Chloramphenicol Detection by ELISA Using Artificial Antibody
以IC%(氯霉素对酶标抗原和抗体结合反应的抑制率)为纵坐标,氯霉素标准品的对数为横坐标绘制直接竞争ELISA检测氯霉素的标准曲线,如图1所示。 Take IC% (the inhibition rate of chloramphenicol on the enzyme-labeled antigen and antibody binding reaction) as the ordinate, and the logarithm of the chloramphenicol standard as the abscissa to draw a standard curve for direct competition ELISA detection of chloramphenicol, as shown in Figure 1 Show.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101522466A CN103278622A (en) | 2013-04-27 | 2013-04-27 | Preparation method of 96-well enzyme label plate chloramphenicol molecularly imprinted polymer film |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101522466A CN103278622A (en) | 2013-04-27 | 2013-04-27 | Preparation method of 96-well enzyme label plate chloramphenicol molecularly imprinted polymer film |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103278622A true CN103278622A (en) | 2013-09-04 |
Family
ID=49061201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101522466A Pending CN103278622A (en) | 2013-04-27 | 2013-04-27 | Preparation method of 96-well enzyme label plate chloramphenicol molecularly imprinted polymer film |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103278622A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105111370A (en) * | 2015-09-29 | 2015-12-02 | 徐州工程学院 | Chloramphenicol molecularly imprinted polymer and preparation method thereof |
CN105732890A (en) * | 2016-04-30 | 2016-07-06 | 中国科学院新疆理化技术研究所 | Preparation method of gossypol molecularly imprinted polymer |
CN108051594A (en) * | 2017-12-20 | 2018-05-18 | 河南联博生物科技有限公司 | A kind of latex enhancing immune turbidimetry quantitatively detects the reagent of chloramphenicol |
CN113354818A (en) * | 2021-06-15 | 2021-09-07 | 天津科技大学 | Preparation method and application of microporous plate for high-throughput rapid detection of kaempferol |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101564681A (en) * | 2009-06-03 | 2009-10-28 | 中国农业科学院农业质量标准与检测技术研究所 | Solid phase extraction column of chloromycetin molecularly imprinted polymer and preparation method thereof |
CN101650335A (en) * | 2009-07-31 | 2010-02-17 | 宇星科技发展(深圳)有限公司 | Molecularly imprinted membrane detection device for tetracycline and preparation and detection methods thereof |
CN102288749A (en) * | 2011-07-28 | 2011-12-21 | 山东农业大学 | Dipterex bionic enzyme linked immunosorbent detection method |
CN102382247A (en) * | 2010-09-03 | 2012-03-21 | 中国科学院过程工程研究所 | Preparation method of molecular imprinting polymer micro-sphere with uniform size and application |
-
2013
- 2013-04-27 CN CN2013101522466A patent/CN103278622A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101564681A (en) * | 2009-06-03 | 2009-10-28 | 中国农业科学院农业质量标准与检测技术研究所 | Solid phase extraction column of chloromycetin molecularly imprinted polymer and preparation method thereof |
CN101650335A (en) * | 2009-07-31 | 2010-02-17 | 宇星科技发展(深圳)有限公司 | Molecularly imprinted membrane detection device for tetracycline and preparation and detection methods thereof |
CN102382247A (en) * | 2010-09-03 | 2012-03-21 | 中国科学院过程工程研究所 | Preparation method of molecular imprinting polymer micro-sphere with uniform size and application |
CN102288749A (en) * | 2011-07-28 | 2011-12-21 | 山东农业大学 | Dipterex bionic enzyme linked immunosorbent detection method |
Non-Patent Citations (1)
Title |
---|
杜幸洁等: "氯霉素分子印迹膜的制备", 《2012年中国水产学会学术年会论文摘要集》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105111370A (en) * | 2015-09-29 | 2015-12-02 | 徐州工程学院 | Chloramphenicol molecularly imprinted polymer and preparation method thereof |
CN105732890A (en) * | 2016-04-30 | 2016-07-06 | 中国科学院新疆理化技术研究所 | Preparation method of gossypol molecularly imprinted polymer |
CN108051594A (en) * | 2017-12-20 | 2018-05-18 | 河南联博生物科技有限公司 | A kind of latex enhancing immune turbidimetry quantitatively detects the reagent of chloramphenicol |
CN113354818A (en) * | 2021-06-15 | 2021-09-07 | 天津科技大学 | Preparation method and application of microporous plate for high-throughput rapid detection of kaempferol |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tarannum et al. | Molecularly imprinted polymers as receptors for assays of antibiotics | |
CN103739846B (en) | A kind of preparation method of quantum dot fluorescence imprinted polymer | |
CN107121402A (en) | Chloramphenicol detection method in a kind of water body based on metal organic framework compound mimetic enzyme catalysis characteristic | |
Yang et al. | Surface molecularly imprinted magnetic MOFs: A novel platform coupled with magneto electrode for high throughput electrochemical sensing analysis of oxytetracycline in foods | |
CN103278622A (en) | Preparation method of 96-well enzyme label plate chloramphenicol molecularly imprinted polymer film | |
CN104672476A (en) | Preparation method of rare-earth fluorescent molecularly imprinted membrane and application of rare-earth fluorescent molecularly imprinted membrane | |
CN102721813A (en) | Homogeneous luminous immunoassay assay kit for prostate specific antigen and detection method therefor | |
CN102116759B (en) | Selective electrode of tetracycline drugs and preparation method thereof | |
Su-Ping et al. | Progress in molecular imprinting electrochemiluminescence analysis | |
Chansud et al. | Ultrasensitive and highly selective fluorescence probe of nitrogen-doped graphene quantum dots and zinc oxide decorated carbon foam incorporated molecularly imprinted polymer for trace sparfloxacin determination | |
CN109187506A (en) | Based on molecularly imprinted polymer-ferroso-ferric oxide Electrochemiluminescsensor sensor preparation method and application | |
CN103760052B (en) | A kind of Microcystin piezoelectric detection sensor based on molecular imprinting | |
CN103018434A (en) | Multi-index detecting device, kit and application thereof | |
Wang et al. | Development of a Biomimetic Enzyme‐linked Immunosorbent Assay Method for the Determination of Methimazole in Urine Sample | |
CN104048949B (en) | A kind of preparation method and applications of rare-earth fluorescent trace probe | |
CN104059195B (en) | Preparation method of a trichothecene toxoid molecularly imprinted polymer | |
CN104677889B (en) | Method for detecting alpha fetoprotein by using magnetic immune probe based on luminol functionalization | |
CN109061198A (en) | inhibin A detection kit and preparation method thereof | |
CN104237230B (en) | The quick determination method of epiphysin and its operation vessel combination | |
CN103275271A (en) | Preparation method of chloramphenicol molecularly-imprinted polymer film | |
CN103111260A (en) | Preparation method of dumbbell-shaped molecular imprinting stirring rod | |
CN106124776A (en) | CA724 chemiluminescence immune detection reagent kit and preparation method thereof | |
CN104098740B (en) | A kind of Trichothecenes toxoid molecularly imprinted polymer | |
Fosso Tene et al. | Cryogel monoliths for analyte enrichment by capture and release | |
CN104330562A (en) | High-throughput treponema pallidum specific antibody detection kit and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C05 | Deemed withdrawal (patent law before 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130904 |